All dividend growth stocks have at least this factor in common -- they consistently earn a profit. If this weren't so, it would be impossible to sustain continued dividend growth.

Operating as a leader in the health insurance industry, Elevance Health (NYSE: ELV) is arguably one of the highest-quality dividend growth stocks in the world. But is the stock currently a buy for dividend growth investors? Let's look at Elevance Health's fundamentals and valuation to answer this question.

The same trend that has driven 21.8% annual non-GAAP (adjusted) diluted earnings per share (EPS) for Elevance Health over the last five years appears poised to continue. This is, of course, the tremendous organic growth in the demand for health insurance services that the company provides to nearly 120 million customers. 

Continue reading

Source Fool.com